CJC-1295 + Ipamorelin Cartridge for Injector Pen

🧬 Clinical Overview

What it is:

CJC-1295 and Ipamorelin are two complementary peptides combined into a single formulation to amplify natural growth hormone release. CJC-1295 is a long-acting GHRH analog that raises baseline GH levels, while Ipamorelin is a selective GH secretagogue that triggers a clean GH pulse without significantly affecting cortisol or appetite hormones. Together, they produce a synergistic, more robust GH release than either peptide alone.

Mechanism of Action:

CJC-1295 binds GHRH receptors, extending and elevating baseline growth hormone signaling

Ipamorelin selectively stimulates the ghrelin receptor to trigger a strong, pulsatile GH release

The combination amplifies GH and downstream IGF-1 output beyond either peptide individually

Ipamorelin's selectivity avoids the cortisol and prolactin spikes seen with older GH secretagogues